BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...

Join Innovate Carolina’s Office of Technology Commercialization for its 2025 Celebration of Inventorship, an evening dedicated to recognizing UNC’s distinguished inventors. This event will feature ...

Following a regulatory setback last year, Satsuma Pharmaceuticals Inc. has won approval for its nasal powder migraine treatment device from the U.S. Food and Drug Administration. Satsuma, a unit of a ...

The recent Accelerate NC Career Celebration at the North Carolina Biotechnology Center brought together key players in the growing ecosystem that makes North Carolina a global leader in life sciences ...

Grifols, already the largest private employer in Johnston County, is about to get even bigger. The Spanish biotherapeutics company is investing $210 million in two new facilities at its manufacturing ...

Fortune 500 medical technology firm Stryker (NYSE: SYK), based in Kalamazoo, Michigan, has acquired Durham-based HyperBranch Medical Technology, Inc., for $220 million. HyperBranch CEO Jeff Clark has ...

Medicago and Mitsubishi this morning announced that Japan-based Mitsubishi Tanabe Pharma will acquire the Canadian vaccine company for $357 million. Medicago operates a facility in Research Triangle ...

When singer songwriter Joni Mitchell wrote “...you don’t know what you’ve got ‘til it’s gone,” she didn’t know Thomas F. Tedder, Ph.D. Tedder, the Alter Geller Professor for Research in Immunology at ...

Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner. She will help expand the firm’s Specialized Fund Management business – ...